ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Contaminants in water used for hemodialysis

Contaminants in water used for hemodialysis
Literature review current through: Jan 2024.
This topic last updated: Jun 20, 2022.

INTRODUCTION — Water used to prepare dialysis fluid is derived from sources of drinking water, such as a large municipal water supply, a small community water system, or from a well. Detailed requirements for safe drinking water are set out in the World Health Organization (WHO) Guidelines for drinking water quality [1]. The WHO guidelines include minimum standards of safe practice and numerical "guideline values" for contaminants in drinking water and indicators of drinking water quality. These requirements are also incorporated into the Safe Drinking Water Act (SDWA) in the United States [2] and the European Drinking Water Directive in the European Union [3], and compliance with them is legally enforceable in both jurisdictions. In spite of this, municipal drinking water does not always meet the regulatory requirements [4-8]. Additionally, residents drawing their drinking water from private wells face higher risks of exposure to waterborne contaminants than do those served by regulated community water supplies [9]. Regulatory noncompliance is not limited to chemical contaminants but can also occur for pathogens including bacteria, viruses, and parasites [10-12].

Drinking water is not safe for use in hemodialysis applications and must, therefore, be treated further at the point of use. Healthy individuals seldom have a weekly water intake of more than 14 liters (ie, 2 L/day). However, a typical hemodialysis prescription (thrice weekly for four hours per session with a dialysis fluid flow rate of 800 mL/min) exposes the patient to more than 500 liters of water per week across the semipermeable membrane of the hemodialyzer. Because of this substantially higher exposure to contaminants in water, additional treatment of water used for preparation of dialysis fluid is required.

This topic discusses the contaminants that can be present in drinking water and pose a risk to patients receiving hemodialysis, the safe levels of those contaminants in water used for hemodialysis, and the clinical risks to patients on hemodialysis associated with them. In this discussion, the term "dialysis water" refers to water that has been treated to meet the requirements of the International Standards Organization (ISO) 23500-3 [13] and that is suitable for use in hemodialysis applications, including the preparation of dialysis fluid, reprocessing of dialyzers, preparation of concentrates, and preparation of substitution fluid for online convective therapies. The term "dialysis fluid" refers to dialysate, which is dialysis water mixed with electrolytes, a buffer, and additional chemicals such as glucose, in accordance with the patient's hemodialysis prescription.

The main processes used for removal of contaminants from water intended for hemodialysis are summarized here (table 1). More detailed information on the design and operation of water treatment systems intended to protect patients from contaminants is discussed elsewhere. (See "Assuring water quality for hemodialysis".)

CLINICALLY RELEVANT CONTAMINANTS — Water used for hemodialysis should comply with the standards developed by the International Standards Organization (ISO) and adopted by many national agencies worldwide [13-17]. These standards define the maximum permissible levels of chemical contaminants (table 2) and microbial contaminants in dialysis water and make recommendations regarding methods for their quantification. (See 'Microbial contaminants' below.)  

Other guidelines issued by professional organizations provide support to clinical and technical staff and help ensure that a standardized approach is used across facilities. Although those guidelines differ in their scope, the permitted levels of chemical and microbiologic contaminants in dialysis water mirror the levels provided in the ISO standards (table 2) [17-20].

Contaminant exposure can be associated with clinical manifestations that are acute in onset (at the time of exposure) or that develop over time with chronic exposure (table 3 and table 4). Acute events related to water contamination generally occur in a cluster of patients while they are on hemodialysis. However, the severity of these events and their onset during a hemodialysis session can vary between patients. Patients' position on the water distribution loop and the timing of the hemodialysis treatment relative to the contamination event can also impact the clinical presentation. As an example, exposure to residual disinfectant in the water supply predominantly affects patients who are most proximal to the water supply during the first treatment session following disinfection. Chronic exposure to water contaminants is more difficult to identify. Water contamination should be suspected when multiple patients are affected while receiving hemodialysis at the same facility.

Chemical contaminants and trace elements with known toxicity in hemodialysis patients

Aluminum — Salts of aluminum, such as alum, are added to drinking water to facilitate chemical precipitation and flocculation of colloidal particles (turbidity) and microbes. Prior to the widespread use of reverse osmosis in the treatment of water, patients on hemodialysis were at risk of chronic exposure to aluminum. The chronic exposure to aluminum led to neurologic injury including speech abnormalities, myoclonic muscle spasms, seizures, personality changes, and other manifestations (table 3) [21,22]. (See "Aluminum toxicity in chronic kidney disease" and "Seizures in patients undergoing hemodialysis".)

While a retrospective cohort study indicated that a serum aluminum level of ≥6 ng/mL was independently associated with all-cause death in patients on hemodialysis [23], the prevalence of abnormal aluminum levels in such patients is presently low [24,25], and aluminum toxicity is rare [26,27]. However, occasional, sporadic outbreaks of aluminum intoxication associated with inadequately treated water continue to be reported [28-30].  

Historically, based on the risk of aluminum toxicity among patients on hemodialysis, routine measurements of plasma aluminum concentration were performed [31]. With improvements in hemodialysis and water treatment technologies, the utility and cost effectiveness of such measurements have been questioned [32,33]. It is reasonable to monitor for patient exposure to aluminum during hemodialysis by regularly verifying the performance of the water treatment system. The measurement of plasma aluminum levels should be limited to patients in whom there is a high risk of overload from over-the-counter medications, as well as those using parenteral products [34]. Commonly prescribed medications such as dipyrone, erythropoietin, and iron sulfate may also be potential sources of aluminum exposure [35]. Newer hemodialysis techniques such as online hemodiafiltration may also represent a potential risk due to dialysis water being used to prepare 25 to 35 L of substitution fluid for infusion directly into the blood.

Copper and zinc — Copper and zinc can leach from metal pipes or plumbing, notably if the water is soft and acidic. Both metals have been associated with anemia and fatal hemolysis in patients on hemodialysis but are removed from water by reverse osmosis (table 3 and table 1) [36-38].

Fluoride — Fluoride is added to drinking water in low concentrations to prevent dental caries; it may also be naturally present in ground water. Over-fluoridation of drinking water has occurred [39,40].

Patients with reduced glomerular filtration rates (GFRs) have a decreased ability to excrete fluoride and may develop skeletal fluorosis even at 1 part per million (ppm) fluoride concentration that is normally present in the drinking water (table 2) [41]. Excess fluoride has been associated with increased osteoid parameters and decreased bone microhardness in patients with renal osteodystrophy [42]. It is unclear if there is any association between osteomalacia or osteoporosis and chronic exposure to low levels of fluoride that remain after reverse osmosis [26,43].

During the preparation of dialysis fluid, fluoride is removed either by reverse osmosis or by deionization (table 1). Deionizers have a limited capacity for anion removal. If operated to exhaustion, anions previously removed by the deionizer may be released back into the water. This can lead to intoxication from acute exposure to high levels of fluoride and can manifest as severe pruritus and fatal ventricular fibrillation (table 3) [44].

Lead — Lead can leach from metal plumbing or be present in public water from changes in water treatment practices. As an example, the introduction of monochloramine as a disinfectant for drinking water led to elevated lead levels from corrosion of lead piping [45]. Children are known to be at increased risk from lead exposure. Chronic kidney disease confers a similar susceptibility as patients excrete lead less effectively, culminating in circulating levels of lead that are many fold higher than those in individuals with normal kidney function [46]. Studies have indicated that lead levels commonly found in drinking water may impact hemoglobin concentrations, response to erythropoietin stimulating agents, and iron deficiency [47,48]. Elevated levels of lead in patients on hemodialysis have also been linked to uremic pruritus (table 3) [49-51]. Lead is removed from water by reverse osmosis (table 1).

Clinical manifestations of lead toxicity are discussed elsewhere. (See "Lead exposure, toxicity, and poisoning in adults", section on 'Clinical manifestations'.)

Nitrates — Nitrates are commonly present in fertilizers and find their way into water sources. Violations in the maximum enforceable limit of nitrate (as nitrogen) for drinking water (10 mg/L [or 10 ppm]) are common (table 2) [52]. Elevated levels of nitrate can cause anemia and methemoglobinemia in hemodialysis patients (table 3) [53-55]. (See "Methemoglobinemia".)

Nitrates are removed from the drinking water by reverse osmosis (table 1).

Sulfate — Sulfate (SO4) from industrial discharges or from naturally occurring minerals is found in many water supplies. It may also result from the use of iron sulfate as a flocculent for water treatment. At levels >200 mg/L in dialysis water (table 1), sulfate can cause nausea, vomiting, and metabolic acidosis (table 3) [56]. However, these effects have not been observed when the level remains <100 mg/L (that which is permitted in dialysis water).

Trace elements — Trace elements can enter the water supply from naturally occurring minerals or from industrial discharges. A deficiency of essential trace elements and an excess of potentially toxic trace elements are common in patients on hemodialysis [54,57,58]. They are removed from water by reverse osmosis (table 1). Apart from selenium and chromium, the permitted levels of barium, silver, cadmium, mercury, arsenic, thallium, and vanadium are set at 10 percent of the value permitted in drinking water by the United States Environmental Protection Agency (EPA) (table 2). For selenium and chromium, the zero-transfer level is set [15]. The zero-transfer level is the concentration of the element in the dialysis water at which no transfer (by diffusion down a concentration gradient) occurs between dialysis fluid and plasma. For selenium and chromium, a zero-transfer level is higher than 10 percent of the value permitted in drinking water.

Trace metals such as cadmium, arsenic, mercury, chromium, and aluminum may be toxic to bone cells even at low concentrations (table 2 and table 3) [59]. Despite the zero-transfer level, increased levels of chromium have been reported in the serum and bone of hemodialysis patients [60-62]. The most likely source of this chromium is dietary intake. Although there is no evidence of dialysis water being a potential source of chromium, intoxication is possible from the salts added to the dialysis fluid or from leaching of the hemodialysis machine [60,61].

Electrolytes present in dialysis fluid — Electrolytes such as sodium, potassium, calcium, and magnesium are present in drinking water at various concentrations and are removed during water treatment prior to its use for hemodialysis. This is to ensure that the residual electrolytes present in dialysis water do not contribute to clinically significant concentrations during the preparation of dialysis fluid. Electrolytes are generally well removed by reverse osmosis (table 1). Divalent cations, such as calcium and magnesium, are usually removed by water softening prior to reverse osmosis to prevent scaling of the reverse osmosis membrane (table 1).

Accidental softener malfunction during hemodialysis can lead to hypernatremia [63], while elevated levels of calcium from failure of a reverse osmosis unit or softener can lead to hard water syndrome, which manifests with nausea, vomiting, weakness, and hypertension (table 3) [64,65]. Hard water syndrome can also be associated with an increased risk of arteriovenous fistula thrombosis [65].

Disinfectants added to drinking water — Disinfectants are added to drinking water at the municipal level to ensure that the water complies with the national standard for total coliform bacteria in drinking water. Disinfectants commonly used for this purpose include chlorine, monochloramine, and chlorine dioxide.

Chlorine and monochloramine — In addition to disinfecting water, chlorine is also a strong oxidizing agent that can interact with contaminants in the water to form byproducts of disinfection, such as trichloromethane, chloroacetic acids, and chlorite. These substances are considered harmful and are regulated under the Safe Drinking Water Act [2]. Chlorine can also corrode copper pipes, leading to an increase in the copper level of water. Such an increase in copper can be mitigated by controlling the pH and/or adding orthophosphate to the water [66]. Chlorine also oxidizes iron, manganese, and taste and odor compounds present in water. In addition, it removes color from the water, decreases hydrogen sulfide levels, and aids in other water treatment processes, such as sedimentation and filtration. 

Chloramines are the reaction products of chlorine and ammonia, of which monochloramine is the most common. Monochloramine is widely chosen as a disinfectant for drinking water due to certain advantages compared with chlorine, such as: maintenance of its disinfectant activity for a prolonged period of time; lack of alteration of the taste or smell of drinking water; and a lower likelihood of reacting with organic matter to produce trihalomethanes that are associated with health risks [67]. Chlorine and monochloramine are removed by carbon filtration. The removal of chlorine and monochloramine is essential before the reverse osmosis step to prevent damage to the reverse osmosis membrane (table 1).

Monochloramine-contaminated dialysis fluid can cause hemolysis, hemolytic anemia, and methemoglobinemia [68-73], and has also been associated with erythropoietin resistance (table 3 and table 4) [74]. (See "Methemoglobinemia".)

Chlorine dioxide — Chlorine dioxide is used as a disinfectant by a small number of municipal water suppliers. Thus, residual chlorine dioxide and its oxychlorine byproducts, such as chlorite and chlorate, may be present in drinking water. In the United States, the permitted Mean Residual Disinfection Level of chlorine dioxide for drinking water is 0.8 mg/L, and the permitted Maximum Contaminant Level for the byproduct, chlorite, is 1.0 mg/L. In the United Kingdom, the maximum permitted level for the combined concentrations of residual chlorine dioxide and chlorite is 0.5 mg/L. Chlorine dioxide and its oxychlorine byproducts are removed by carbon filtration (table 1).

There is little information about the toxicity of chlorine dioxide and its byproducts to hemodialysis patients. A limited study of 17 patients unknowingly treated with dialysis water disinfected with chlorine dioxide showed no evidence of adverse effects [75]. The dialysis water contained 0.02 to 0.08 mg/L of chlorite and no detectable chlorate. However, the patient population was small and potentially important hematologic parameters were not measured. Despite a lack of clear evidence of harm, chloride dioxide should be considered a contaminant with similar clinical toxicity to chlorine and monochloramine until more information is available (table 3).

Disinfectants added by hospitals or hemodialysis facilities

Hydrogen peroxide and silver-stabilized peroxide — Hydrogen peroxide and silver-stabilized peroxide can be used to suppress growth of legionella in storage tanks and distribution systems of health care premises that include hemodialysis units. The presence of residual hydrogen peroxide and silver-stabilized hydrogen peroxide in dialysis water has been associated with cyanosis and methemoglobinemia, and can be removed by carbon filtration (table 1) [76-80]. (See "Methemoglobinemia".)

Peracetic acid and sodium hypochlorite (bleach) — Dialysis water treatment and distribution systems routinely undergo disinfection or descaling to prevent bacterial growth. (See "Assuring water quality for hemodialysis", section on 'Disinfection'.)

During disinfection, a cold sterilant such as peracetic acid or sodium hypochlorite is added to the water and circulated for a period of time. The sterilant is then flushed from the system using water produced by the water treatment system. The flushed water is then tested for the presence of residual sterilant using test strips.

However, if flushing of the system is inadequate, patients can be inadvertently exposed to the sterilant. Typically, the risk of exposure is the highest for patients treated on the first shift (after sterilization) who are in closest proximity to the water treatment system. Exposure to sodium hypochlorite can be serious and is usually manifested by hemolysis, hyperkalemia, hypoxia, and cardiac arrest (table 3) [81,82]. Exposure to peracetic acid can also result in hemolysis [83]. Peracetic acid and sodium hypochlorite are removed by carbon filtration (table 1).

Microbial contaminants

Bacteria and endotoxin — In addition to limits for chemical contaminants, the ISO standard also specifies the maximum permitted levels for bacteria and endotoxins in the dialysis water. Adherence to the maximum permitted levels is particularly important when the ultimate use of the water is for the on-line preparation of sterile, nonpyrogenic substitution solution for hemodiafiltration. (See "Technical aspects of hemodiafiltration".)

Bacteria or endotoxins can also contaminate dialyzers that are reused. This is usually by way of the water that enters the blood compartment of the dialyzer when it is being processed for reuse. These contaminants can then travel from the blood compartment into the patient's bloodstream, causing bacteremia, endotoxinemia, and pyrogenic reactions [84-86]. (See "Reuse of dialyzers".)

Bacteriostatic agents, chlorine and monochloramine, that are added for disinfection of drinking water get removed from dialysis water (see "Assuring water quality for hemodialysis", section on 'Activated carbon beds or filters'). This makes the water susceptible to bacterial proliferation. If such proliferation goes unchecked, a biocide-resistant biofilm can develop and serve as an ongoing source of bacterial contaminants [87]. Improvements in membrane technology have led to development of dialyzer membranes that provide an effective barrier against bacteria and endotoxins. However, small bacterial fragments still have the potential to cross some dialyzer membranes [88-92]. The repeated exposure to such bacterial fragments is associated with a microinflammatory response, which is believed to contribute to the long-term morbidity among patients on hemodialysis [93].

Typical culture and colony count methods for detecting bacteria are limited in their ability to detect low concentrations of fastidious and slow-growing bacteria that are typically present in drinking water. There is a growing interest in developing rapid alternative analytical methods for bacterial quantification [94]. For the detection of microbial products, such as peptidoglycans, bacterial DNA, mycoplasma, fungi, and viruses, specialized assays are required. However, there are no established standards for such testing in monitoring dialysis water [95,96].

Cyanobacterial toxins — Surface water can be contaminated by cyanobacteria. Cyanobacteria produce microcystins that are harmful to humans. Most municipal water treatment plants do not regularly screen for microcystins in the water supply, unless cyanobacteria are present in the source water. If identified, remedial action is taken so that the water complies with health advisory recommendations detailed by the World Health Organization (WHO) and the United States EPA [1,97]. However, complete removal of microcystins is challenging due to the possibility of dissolved extracellular toxin that can bypass the treatment process [98].

Hemodialysis patients exposed to dialysis water contaminated with cyanotoxins may develop fatal acute illness [3,99-102]. However, ensuring safety of hemodialysis patients from these toxins is complicated by a lack of monitoring and regulation of cyanotoxins in source drinking water, lack of established safe levels in dialysis water, and insufficient knowledge regarding the methods to eliminate them. Thus, hemodialysis centers should be aware of potential cyanotoxins in dialysis water, particularly when it is sourced from surface water prone to cyanobacterial blooms. Hemodialysis facilities should establish a means of communication with their municipal water providers so that they are notified of any cyanobacterial blooms in the surface waters used for their supply.

In the absence of concentration-toxicity data, the United States and international standards for dialysis water set the maximum allowable levels of potentially toxic contaminants at 10 percent of the levels allowed in drinking water. On that basis, and using the WHO provisional drinking water guideline for the concentration of microcystin-LR at 1 microgram/L based on lifetime exposure, the maximum concentration for microcystins in dialysis water would be 10 percent of 1 microgram/L, or 0.1 microgram/L. While this level is below those associated with prior outbreaks in Brazil [100,102], it is difficult to be confident that a concentration of 0.1 microgram/L can be accurately and routinely detected using current analytical methodology.

CONTAMINANTS WITH UNCERTAIN TOXICITY IN HEMODIALYSIS PATIENTS

Organic compounds — Drinking water supplies are known to contain numerous organic contaminants including pesticides, herbicides, and polycyclic aromatic hydrocarbons. Many can be removed by nanofiltration, reverse osmosis, and granular-activated carbon; however, adequate removal by granular-activated carbon is highly dependent upon the size of the carbon beds and the availability of binding sites. Per- and polyfluoroalkyl substances (PFAS) are also present in drinking water supplies. Such compounds are known to affect the endocrine, immune, and metabolic systems and are difficult to remove from water although there are several emerging and innovative methods for reducing PFAS in drinking water, including chemical and electrochemical oxidation, ozo fractionation, and novel sorbents [103].

Only a small number of organic compounds have received study in patients on hemodialysis, such as trichloroethylene [104] and bisphenol A (BPA), also known as 2,2-Bis(4-hydroxyphenyl)propane, which is used in the manufacture of plastics [105,106]. BPA is removed from water by nanofiltration and reverse osmosis [107]. However, BPA can be present in plastic components of the water distribution system downstream of the water treatment facility [105,108], so that patients who receive online hemodiafiltration can still be exposed to BPA and its chlorinated derivatives [108]. Although the toxic effect of BPA burden in patients on dialysis remains controversial, the mere possibility of enhancing oxidative stress and inflammation in these patients merits the desirability of reducing exposure [109].

If the presence of an organic compound has been demonstrated in dialysis water, then routine monitoring is advised, and it is reasonable to aim for a concentration that is 10-fold lower than the requirement for drinking water.

Microplastics — There is widespread presence of microplastics (<5 mm in diameter) in drinking water [110], and their removal remains a challenge, although experimental studies have demonstrated that they are retained in aged (ie, biofilm-coated) sand filters [111]. Their potential health impact is under study. While animal studies have demonstrated bioaccumulation of microplastics [112], there are knowledge gaps. The impact of exposure in patients on dialysis is not known, although microplastics are unlikely to cross reverse osmosis or dialyzer membranes [113,114].

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Dialysis".)

SUMMARY AND RECOMMENDATIONS

General principles – Drinking water, which is usually sourced from a large municipal water supply, a small community water system, or a well, is not safe for hemodialysis and must, therefore, be treated further at the point of use. (See 'Introduction' above.)

Clinically relevant contaminants – The International Standards Organization (ISO) defines the maximum permissible levels of chemical (table 2) and microbial contaminants present in dialysis water. Lack of adequate contaminant removal can result in clinical manifestations of toxicity among patients on hemodialysis. Toxicity may be acute in onset (at the time of exposure) or may develop over time with chronic exposure (table 3 and table 4). Contamination should be suspected when multiple patients undergoing hemodialysis at the same facility develop similar symptoms. (See 'Clinically relevant contaminants' above.)

Chemical contaminants – Certain chemical contaminants, such as aluminum, copper, zinc, fluoride, lead, nitrates, sulfate, and trace elements may inadvertently enter the water supply from various environmental sources. These chemicals require removal by reverse osmosis (table 1). (See 'Chemical contaminants and trace elements with known toxicity in hemodialysis patients' above.)

Electrolytes – Dialysis water can also contain excess amounts of electrolytes (eg, calcium, magnesium) requiring removal (table 1). (See 'Electrolytes present in dialysis fluid' above.)

Disinfectants – Disinfectants, such as chlorine, monochloramine, and chlorine dioxide, are added to the water supply to limit growth of coliform bacteria. Exposure to these can result in hemolysis, hemolytic anemia, methemoglobinemia, and erythropoietin resistance (table 3 and table 4). They are removed by carbon filtration (table 1). (See 'Disinfectants added to drinking water' above.)

Disinfectants (eg, hydrogen peroxide), which may be added by hospitals or hemodialysis units to sanitize water distribution systems and hemodialysis machines, need to be monitored and, if present, removed by carbon filtration (table 1). (See 'Disinfectants added by hospitals or hemodialysis facilities' above.)

Microbial contaminants – Adherence to the specified limits for bacteria and endotoxin, supported by infection prevention practices in hemodialysis patient care, substantially lowers the risk of bacteremia, endotoxinemia, and pyrogenic reactions. In addition, surface water can be contaminated by cyanobacteria that can produce microcystins, which can lead to fatal illness in humans. Hemodialysis facilities should establish a means of communication with their municipal water providers to ensure that they are notified of any cyanobacterial blooms in the surface waters used for their supply. (See 'Microbial contaminants' above.)

  1. Guidelines for drinking-water quality: Fourth edition incorporating the first addendum, World Health Organization, Geneva 2017. Available online at: https://www.who.int/publications/i/item/9789240045064.
  2. US Environmental Protection Agency. National Primary Drinking Water Regulations. https://www.epa.gov/ground-water-and-drinking-water/national-primary-drinking-water-regulations/ (Accessed on June 1, 2022).
  3. European Union. Council Directive 2020/2184 of 16 December 2020 on the quality of water intended for human consumption (recast). Available at: https://eur-lex.europa.eu/eli/dir/2020/2184/oj. (Accessed on June 1, 2022.).
  4. Allaire M, Wu H, Lall U. National trends in drinking water quality violations. Proc Natl Acad Sci U S A 2018; 115:2078.
  5. DeSimone LA, McMahon PM, Rosen MR. The quality of our Nation's waters. Water quality in principal aquifers of the United States, 1991-2010. National Water-Quality Assessment Program; US Geological Survey Circular 1360, 2015.
  6. Ander EL, Watts MJ, Smedley PL, et al. Variability in the chemistry of private drinking water supplies and the impact of domestic treatment systems on water quality. Environ Geochem Health 2016; 38:1313.
  7. Pieper KJ, Martin R, Tang M, et al. Evaluating Water Lead Levels During the Flint Water Crisis. Environ Sci Technol 2018; 52:8124.
  8. Pennino MJ, Leibowitz SG, Compton JE, et al. Patterns and predictions of drinking water nitrate violations across the conterminous United States. Sci Total Environ 2020; 722:137661.
  9. MacDonald Gibson J, Pieper KJ. Strategies to Improve Private-Well Water Quality: A North Carolina Perspective. Environ Health Perspect 2017; 125:076001.
  10. Macler BA, Merkle JC. Current knowledge on groundwater microbial pathogens and their control. Hydrogeol J 2000; 8:29.
  11. Pang X, Gao T, Qiu Y, et al. The prevalence and levels of enteric viruses in groundwater of private wells in rural Alberta, Canada. Water Res 2021; 202:117425.
  12. Burch TR, Stokdyk JP, Rice N, et al. Statewide Quantitative Microbial Risk Assessment for Waterborne Viruses, Bacteria, and Protozoa in Public Water Supply Wells in Minnesota. Environ Sci Technol 2022; 56:6315.
  13. ISO 23500-3: Preparation and quality management of fluids for haemodialysis and related therapies — Part 3: Water for haemodialysis and related therapies. https://www.iso.org/standard/67612.html (Accessed on June 1, 2022).
  14. ISO 23500-1: Preparation and quality management of fluids for haemodialysis and related therapies — Part 1: General requirements. https://www.iso.org/standard/67610.html (Accessed on June 1, 2022).
  15. ISO23500-2: Preparation and quality management of fluids for haemodialysis and related therapies — Part 2: Water treatment equipment for haemodialysis applications and related therapies. https://www.iso.org/standard/67611.html (Accessed June 1, 2022).
  16. ISO235500-4: Preparation and quality management of fluids for haemodialysis and related therapies — Part 4: Concentrates for haemodialysis and related therapies. https://www.iso.org/standard/67613.html (Accessed June 1, 2022).
  17. ISO23500-5: Preparation and quality management of fluids for haemodialysis and related therapies - Part 5: Quality of dialysis fluid for haemodialysis and related therapies. International Organization for Standardization Geneva, 2019. https://www.iso.org/standard/67614.html (Accessed June 1, 2022).
  18. Hoenich NA, Mactier R, Morgan I, et al. Guideline on water treatment systems, dialysis water and dialysis fluid for haemodialysis and related therapies. Renal Association and the Association of Renal Technologists, 2016. Available at: https://www.renaltech.net/uploads/1/3/6/4/136400/guideline_on_water_treatment_systems_dialysis_water_and_related_therapies__jan_2016.pdf. (Accessed June 1, 2022).
  19. Pérez-García R, García Maset R, Gonzalez Parra E, et al. Guideline for dialysate quality of Spanish Society of Nephrology (second edition, 2015). Nefrologia 2016; 36:e1.
  20. Kawasaki T, Uchino J, Shinoda T, et al. Guidance of technical management of dialysis water and dialysis fluid for the Japan Association for Clinical Engineering Technologists. Blood Purif 2009; 27 Suppl 1:41.
  21. Alfrey AC, LeGendre GR, Kaehny WD. The dialysis encephalopathy syndrome. Possible aluminum intoxication. N Engl J Med 1976; 294:184.
  22. Parkinson IS, Ward MK, Kerr DN. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis. J Clin Pathol 1981; 34:1285.
  23. Tsai MH, Fang YW, Liou HH, et al. Association of Serum Aluminum Levels with Mortality in Patients on Chronic Hemodialysis. Sci Rep 2018; 8:16729.
  24. Jaffe JA, Liftman C, Glickman JD. Frequency of elevated serum aluminum levels in adult dialysis patients. Am J Kidney Dis 2005; 46:316.
  25. Chuang PH, Tsai KF, Wang IK, et al. Blood Aluminum Levels in Patients with Hemodialysis and Peritoneal Dialysis. Int J Environ Res Public Health 2022; 19.
  26. Hoenich NA, Levin R. The implications of water quality in hemodialysis. Semin Dial 2003; 16:492.
  27. Seidowsky A, Dupuis E, Drueke T, et al. [Aluminic intoxication in chronic hemodialysis. A diagnosis rarely evoked nowadays. Clinical case and review of the literature]. Nephrol Ther 2018; 14:35.
  28. Simoes J, Barata JD, D'Haese PC, De Broe ME. Cela n'arrive qu'aux autres (aluminium intoxication only happens in the other nephrologist's dialysis centre). Nephrol Dial Transplant 1994; 9:67.
  29. Berend K, van der Voet G, Boer WH. Acute aluminum encephalopathy in a dialysis center caused by a cement mortar water distribution pipe. Kidney Int 2001; 59:746.
  30. Burwen DR, Olsen SM, Bland LA, et al. Epidemic aluminum intoxication in hemodialysis patients traced to use of an aluminum pump. Kidney Int 1995; 48:469.
  31. D'Haese PC, Clement JP, Elseviers MM, et al. Value of serum aluminium monitoring in dialysis patients: a multicentre study. Nephrol Dial Transplant 1990; 5:45.
  32. Gault PM, Allen KR, Newton KE. Plasma aluminium: a redundant test for patients on dialysis? Ann Clin Biochem 2005; 42:51.
  33. Sharma AK, Toussaint ND, Pickering J, et al. Assessing the utility of testing aluminum levels in dialysis patients. Hemodial Int 2015; 19:256.
  34. Gura KM. Aluminum contamination in parenteral products. Curr Opin Clin Nutr Metab Care 2014; 17:551.
  35. Bohrer D, Bertagnolli DC, de Oliveira SM, et al. Drugs as a hidden source of aluminium for chronic renal patients. Nephrol Dial Transplant 2007; 22:605.
  36. Klein WJ Jr, Metz EN, Price AR. Acute copper intoxication. A hazard of hemodialysis. Arch Intern Med 1972; 129:578.
  37. Manzler AD, Schreiner AW. Copper-induced acute hemolytic anemia. A new complication of hemodialysis. Ann Intern Med 1970; 73:409.
  38. Gallery ED, Blomfield J, Dixon SR. Acute zinc toxicity in haemodialysis. Br Med J 1972; 4:331.
  39. Penman AD, Brackin BT, Embrey R. Outbreak of acute fluoride poisoning caused by a fluoride overfeed, Mississippi, 1993. Public Health Rep 1997; 112:403.
  40. Gessner BD, Beller M, Middaugh JP, Whitford GM. Acute fluoride poisoning from a public water system. N Engl J Med 1994; 330:95.
  41. Nayak B, Roy MM, Das B, et al. Health effects of groundwater fluoride contamination. Clin Toxicol (Phila) 2009; 47:292.
  42. Ng AH, Hercz G, Kandel R, Grynpas MD. Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy. Bone 2004; 34:216.
  43. Rao TK, Friedman EA. Editorial: Fluoride and bone disease in uremia. Kidney Int 1975; 7:125.
  44. Arnow PM, Bland LA, Garcia-Houchins S, et al. An outbreak of fatal fluoride intoxication in a long-term hemodialysis unit. Ann Intern Med 1994; 121:339.
  45. Miranda ML, Kim D, Hull AP, et al. Changes in blood lead levels associated with use of chloramines in water treatment systems. Environ Health Perspect 2007; 115:221.
  46. Harari F, Sallsten G, Christensson A, et al. Blood Lead Levels and Decreased Kidney Function in a Population-Based Cohort. Am J Kidney Dis 2018; 72:381.
  47. Danziger J, Mukamal KJ, Weinhandl E. Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD. J Am Soc Nephrol 2021; 32:2425.
  48. Danziger J, Mukamel K. Levels of lead in residential drinking water and iron deficiency among patients with end stage kidney disease. Kidney360 2022; Publish ahead of print.
  49. Davenport A, Murcutt G, Whiting S. Cross-sectional audit of blood lead levels in regular outpatient haemodialysis patients dialysing in north London. Nephrology (Carlton) 2009; 14:476.
  50. Kathuria P, Nair B, Schram D, Medlock R. Outbreak of lead poisoning in a hemodialysis unit. J Am Soc Nephrol 2004; 15:617A.
  51. Weng CH, Hsu CW, Hu CC, et al. Blood lead level is a positive predictor of uremic pruritus in patients undergoing hemodialysis. Ther Clin Risk Manag 2017; 13:717.
  52. Pennino MJ, Compton JE, Leibowitz SG. Trends in Drinking Water Nitrate Violations Across the United States. Environ Sci Technol 2017; 51:13450.
  53. Salvadori M, Martinelli F, Comparini L, et al. Nitrate induced anaemia in home dialysis patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 1985; 21:321.
  54. Suzuki MN, Fregonesi BM, Machado CS, et al. Hemodialysis Water Parameters as Predisposing Factors for Anemia in Patients in Dialytic Treatment: Application of Mixed Regression Models. Biol Trace Elem Res 2019; 190:30.
  55. Carlson DJ, Shapiro FL. Methemoglobinemia from well water nitrates: a complication of home dialysis. Ann Intern Med 1970; 73:757.
  56. Comty C, Luehmann D, Wathen R, Shapiro F. Prescription water for chronic hemodialysis. Trans Am Soc Artif Intern Organs 1974; 20A:189.
  57. Tonelli M, Wiebe N, Bello A, et al. Concentrations of Trace Elements and Clinical Outcomes in Hemodialysis Patients: A Prospective Cohort Study. Clin J Am Soc Nephrol 2018; 13:907.
  58. Tonelli M, Wiebe N, Hemmelgarn B, et al. Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med 2009; 7:25.
  59. Zofkova I, Davis M, Blahos J. Trace elements have beneficial, as well as detrimental effects on bone homeostasis. Physiol Res 2017; 66:391.
  60. Prodanchuk M, Makarov O, Pisarev E, et al. Disturbances of trace element metabolism in ESRD patients receiving hemodialysis and hemodiafiltration. Cent European J Urol 2014; 66:472.
  61. Pietra R, Sabbioni E, Brancaccio D, et al. Evidence for chromium imbalance in dialyzed uremic patients with chronic renal failure Science of the total environment 1988; 71:553.
  62. D'Haese PC, Couttenye MM, Lamberts LV, et al. Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients. Clin Chem 1999; 45:1548.
  63. Nickey WA, Chinitz VL, Kim KE, et al. Hypernatremia from water softener malfunction during home dialysis. JAMA 1970; 214:915.
  64. Freeman RM, Lawton RL, Chamberlain MA. Hard-water syndrome. N Engl J Med 1967; 276:1113.
  65. Leonard H, Pile T. Hard water syndrome: a case series of 30 patients from a London haemodialysis unit. Clin Kidney J 2020; 13:111.
  66. Lytle DA, Liggett J. Impact of water quality on chlorine demand of corroding copper. Water Res 2016; 92:11.
  67. Chowdhury S, Rodriguez MJ, Sadiq R. Disinfection byproducts in Canadian provinces: associated cancer risks and medical expenses. J Hazard Mater 2011; 187:574.
  68. Junglee NA, Rahman SU, Wild M, et al. When pure is not so pure: chloramine-related hemolytic anemia in home hemodialysis patients. Hemodial Int 2010; 14:327.
  69. Eaton JW, Kolpin CF, Swofford HS, et al. Chlorinated urban water: a cause of dialysis-induced hemolytic anemia. Science 1973; 181:463.
  70. Tipple MA, Shusterman N, Bland LA, et al. Illness in hemodialysis patients after exposure to chloramine contaminated dialysate. ASAIO Trans 1991; 37:588.
  71. Pérez-García R, Rodríguez-Benítez P. Chloramine, a sneaky contaminant of dialysate. Nephrol Dial Transplant 1999; 14:2579.
  72. de Torres JP, Strom JA, Jaber BL, Hendra KP. Hemodialysis-associated methemoglobinemia in acute renal failure. Am J Kidney Dis 2002; 39:1307.
  73. Tharmaraj D, Kerr PG. Haemolysis in haemodialysis. Nephrology (Carlton) 2017; 22:838.
  74. Fluck S, McKane W, Cairns T, et al. Chloramine-induced haemolysis presenting as erythropoietin resistance. Nephrol Dial Transplant 1999; 14:1687.
  75. Ames RG, Stratton JW. Effect of chlorine dioxide water disinfection on hematologic and serum parameters of renal dialysis patients. Arch Environ Health 1987; 42:280.
  76. Medarov BI, Pahwa S, Reed S, et al. Methemoglobinemia Caused by Portable Dialysis in the Critically Ill. Crit Care Med 2017; 45:e232.
  77. Gordon SM, Bland LA, Alexander SR, et al. Hemolysis associated with hydrogen peroxide at a pediatric dialysis center. Am J Nephrol 1990; 10:123.
  78. Newbigging N, Peel W, Bell E, Isles C. Unexpected cyanosis in a haemodialysis patient-did someone add hydrogen peroxide to the dialysis water? NDT Plus 2009; 2:158.
  79. Bek MJ, Laule S, Reichert-Jünger C, et al. Methemoglobinemia in critically ill patients during extended hemodialysis and simultaneous disinfection of the hospital water supply. Crit Care 2009; 13:R162.
  80. Davidovits M, Barak A, Cleper R, et al. Methaemoglobinaemia and haemolysis associated with hydrogen peroxide in a paediatric haemodialysis centre: a warning note. Nephrol Dial Transplant 2003; 18:2354.
  81. Katirci Y, Kandis H, Aslan S, et al. Accidental use of sodium hypochlorite instead of haemodialysis solution: a case report. Hong Kong Journal of Emergency Medicine 2010; 17:492.
  82. Hoy RH. Accidental systemic exposure to sodium hypochlorite (Chlorox) during hemodialysis. Am J Hosp Pharm 1981; 38:1512.
  83. Szewczyk M, Grzeszczuk K, Walski T, et al. [Are disinfectant residues remained after cleaning hemodialysis machine procedure safe for patients?]. Przegl Lek 2013; 70:97.
  84. Ribeiro IC, Roza NAV, Duarte DA, et al. Clinical and microbiological effects of dialyzers reuse in hemodialysis patients. J Bras Nefrol 2019; 41:384.
  85. Edens C, Wong J, Lyman M, et al. Hemodialyzer Reuse and Gram-Negative Bloodstream Infections. Am J Kidney Dis 2017; 69:726.
  86. Flaherty JP, Garcia-Houchins S, Chudy R, Arnow PM. An outbreak of gram-negative bacteremia traced to contaminated O-rings in reprocessed dialyzers. Ann Intern Med 1993; 119:1072.
  87. Suman E, Varghese B, Joseph N, et al. The bacterial biofilms in dialysis water systems and the effect of the sub inhibitory concentrations of chlorine on them. J Clin Diagn Res 2013; 7:849.
  88. Lonnemann G, Behme TC, Lenzner B, et al. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria. Kidney Int 1992; 42:61.
  89. Handelman GJ, Megdal PA, Handelman SK. Bacterial DNA in water and dialysate: detection and significance for patient outcomes. Blood Purif 2009; 27:81.
  90. Schindler R, Beck W, Deppisch R, et al. Short bacterial DNA fragments: detection in dialysate and induction of cytokines. J Am Soc Nephrol 2004; 15:3207.
  91. Henrie M, Ford C, Andersen M, et al. In vitro assessment of dialysis membrane as an endotoxin transfer barrier: geometry, morphology, and permeability. Artif Organs 2008; 32:701.
  92. Schepers E, Glorieux G, Eloot S, et al. Assessment of the association between increasing membrane pore size and endotoxin permeability using a novel experimental dialysis simulation set-up. BMC Nephrol 2018; 19:1.
  93. Bossola M, Sanguinetti M, Scribano D, et al. Circulating bacterial-derived DNA fragments and markers of inflammation in chronic hemodialysis patients. Clin J Am Soc Nephrol 2009; 4:379.
  94. Canciu A, Tertis M, Hosu O, et al. Modern analytical techniques for detection of bacteria in surface and wastewaters. Sustainability 2021; 13:7229.
  95. Burger-Kentischer A, Abele IS, Finkelmeier D, et al. A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens. J Immunol Methods 2010; 358:93.
  96. Glorieux G, Schepers E, Schindler R, et al. A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test. Nephrol Dial Transplant 2009; 24:548.
  97. United States Environmental Protection Agency. Health advisories and health effect support documents for cyanotoxins. https://www.epa.gov/cyanohabs/epa-drinking-water-health-advisories-cyanotoxins (Accessed on June 1, 2022).
  98. Kull TP, Sjövall OT, Tammenkoski MK, et al. Oxidation of the cyanobacterial hepatotoxin microcystin-LR by chlorine dioxide: influence of natural organic matter. Environ Sci Technol 2006; 40:1504.
  99. Hilborn ED, Soares RM, Servaites JC, et al. Sublethal microcystin exposure and biochemical outcomes among hemodialysis patients. PLoS One 2013; 8:e69518.
  100. Pouria S, de Andrade A, Barbosa J, et al. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet 1998; 352:21.
  101. Carmichael WW, Azevedo SM, An JS, et al. Human fatalities from cyanobacteria: chemical and biological evidence for cyanotoxins. Environ Health Perspect 2001; 109:663.
  102. Azevedo SM, Carmichael WW, Jochimsen EM, et al. Human intoxication by microcystins during renal dialysis treatment in Caruaru-Brazil. Toxicology 2002; 181-182:441.
  103. Addressing Per- and Polyfluoroalkyl Substances (PFAS) in Drinking Water: Guides for Local and State Leaders. American Association for the Advancement of Science Center for Scientific Evidence in Public Issues. 2021. Available at: https://www.aaas.org/programs/epi-center/pfas-guides.
  104. Poli D, Pavone L, Tansinda P, et al. Organic contamination in dialysis water: trichloroethylene as a model compound. Nephrol Dial Transplant 2006; 21:1618.
  105. Krieter DH, Canaud B, Lemke HD, et al. Bisphenol A in chronic kidney disease. Artif Organs 2013; 37:283.
  106. Shen Y, Liu T, Shi Y, et al. Bisphenol A analogs in patients with chronic kidney disease and dialysis therapy. Ecotoxicol Environ Saf 2019; 185:109684.
  107. Yüksel S, Kabay N, Yüksel M. Removal of bisphenol A (BPA) from water by various nanofiltration (NF) and reverse osmosis (RO) membranes. J Hazard Mater 2013; 263 Pt 2:307.
  108. Bacle A, Dupuis A, Belmouaz M, et al. Overexposure to Bisphenol A and Its Chlorinated Derivatives of Patients with End-Stage Renal Disease during Online Hemodiafiltration. Biomolecules 2019; 9.
  109. Quiroga B. Strategies to Protect Dialysis Patients against Bisphenol A. Biomolecules 2021; 11.
  110. WHO Microplastics in drinking water, Geneva 2019. https://www.who.int/water_sanitation_health/publications/microplastics-in-drinking-water/en/ (Accessed June 1, 2022).
  111. Pulido-Reyes G, Magherini L, Bianco C, et al. Nanoplastics removal during drinking water treatment: Laboratory- and pilot-scale experiments and modeling. J Hazard Mater 2022; 436:129011.
  112. Meng X, Zhang J, Wang W, et al. Effects of nano- and microplastics on kidney: Physicochemical properties, bioaccumulation, oxidative stress and immunoreaction. Chemosphere 2022; 288:132631.
  113. Rahman A, Sarkar A, Yadav OP, et al. Potential human health risks due to environmental exposure to nano- and microplastics and knowledge gaps: A scoping review. Sci Total Environ 2021; 757:143872.
  114. Jiang B, Kauffman AE, Li L, et al. Health impacts of environmental contamination of micro- and nanoplastics: a review. Environ Health Prev Med 2020; 25:29.
Topic 1891 Version 33.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟